Postprandial glucose, together with related hyperinsulinemia and lipidaemia, has been
implicated in the development of chronic metabolic diseases like obesity, type 2 diabetes …

Diabetes is associated with a two to three-fold increase in risk of cardiovascular disease.
However, intensive glucose-lowering therapy aiming at reducing HbA1c to a near-normal …

OBJECTIVE—Hyperglycemia and Its Effect After Acute Myocardial Infarction on
Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (HEART2D) is a …

OBJECTIVE The effect of additional treatment with oral hypoglycemic agents on the
progression of atherosclerosis remains unknown in insulin-treated patients with type 2 …

Background Carotid atherosclerosis is a major cause of stroke, but the conclusion about risk
factors for carotid atherosclerosis is still controversial. The aim of our present meta-analysis …

Hyperglycemia is a major risk factor for both the microvascular and macrovascular
complications in patients with type 2 diabetes. This review summarizes the cardiovascular …

OBJECTIVE The aim of this study was to investigate whether carotid intima-media thickness
(IMT) and brachial-ankle pulse wave velocity (baPWV) add value to the Framingham risk …

Atherosclerosis is a systemic disease that is responsible for most cardiovascular events and
stroke. Epidemiologic studies and intervention trials based on the incidence of acute …

Cardiovascular disease is one of the leading causes of mortality globally. Atherosclerosis is
an important step towards different types of cardiovascular disease. The role of oxidized low …

Introduction: Postprandial glucose excursions negatively affect glycemic control and markers
of cardiovascular health. Pramlintide, an amylinomimetic, is approved for treatment of …